Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Clinical Trials topic
No spam. Unsubscribe anytime.
UT Southwestern oncologist says CPRIT uniquely expands Texans' access to clinical trials
Summary
Dr. David Gerber of UT Southwestern told a meeting that the Cancer Prevention and Research Institute of Texas (CPRIT) has provided clinical-trial support for Texas patients unlike anything he has seen elsewhere, and described basic clinical-trial phases and types.
Dr. David Gerber, a medical oncologist at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern and a professor in the Department of Internal Medicine and the O'Donnell School of Public Health, told a meeting that the Cancer Prevention and Research Institute of Texas (CPRIT) has done more to support cancer clinical trials in Texas than he had observed elsewhere.
"A clinical trial is when a patient is offered a treatment or a new diagnostic test that we can learn about through that patient's experience," Gerber said, describing how trials help clinicians and patients. He explained standard clinical-trial phases, saying small phase 1 trials help establish dosing and safety, phase 2 trials look for initial signs of effectiveness, and phase 3 trials are larger studies that can involve "hundreds or thousands of patients." He also noted that some trials are observational, collecting data from standard treatment, while interventional trials actively assign treatments.
Gerber, who said he has been involved with clinical trials for almost 20 years, praised CPRIT's role in Texas. "What CPRIT has done for clinical trials in the state of Texas, I've never seen done elsewhere or at any other time," he said. "I'm not aware of another agency that can help patients as much as CPRIT does."
He added that before learning about CPRIT's program he had not realized a program like it was needed, and that "now that I'm aware of the program, I can't believe there was ever a time we didn't have it." Gerber closed his remarks by identifying his affiliation and collaboration: "I'm David Gerber, and together with Seapriq, I'm helping Texans conquer cancer."
The transcript records these statements as testimony; there were no motions, votes, or formal actions tied to Gerber's remarks in the provided record. The meeting date, sponsor of the agenda item, and any funding amounts or specific CPRIT awards referenced in connection with his remarks were not specified in the transcript.
